health benefits Page 30

Keyword: health benefits

2443 results found

Canadians employees aged 20 to 29 continue to have the lowest general well-being, with a score of 46.3 out of 100, according to a new report by Dialogue Health Technologies Inc. The report, which analyzes data across five dimensions of well-being — including mood, stress, sleep, activeness and sense of purpose — found Canadians’ average well-being has […]

  • By: Staff
  • November 25, 2024 November 25, 2024
  • 15:00

Seven in 10 (70 per cent) employees say they’re dissatisfied with their employer’s current benefits plan, according to a new survey by Robert Walters Canada. The survey, which polled more than 500 employees, found more than a quarter (27 per cent) agreed the benefits their employer offers are mostly trivial and do more to attract employees […]

  • By: Staff
  • November 25, 2024 November 22, 2024
  • 09:00
Copyright_markovsergei_123RF

The percentage of claimants filing claims for obesity drugs increased by 43 per cent in 2023, according to a new report by GreenShield. The report, which analyzed the insurer’s 2023 claims data, found diabetes medications saw a 13 per cent increase in cost, accounting for nine per cent of total drug costs in 2023. There […]

  • By: Staff
  • November 22, 2024 November 20, 2024
  • 09:00

An article on how a national drug pooling program would impact employer-sponsored benefits plans was the most-read story on BenefitsCanada.com this past week. Here are the top five human resources, benefits, pension and investment stories of the last week: 1. How would a national drug pooling program impact employer-sponsored benefits plans? 2. Leadership changes at the AIMCo […]

  • By: Staff
  • November 22, 2024 November 21, 2024
  • 09:00
Copyright_marchmeena_123RF

In Canada, the average health benefits cost trend for 2025 is estimated to be 7.4 per cent, up from five per cent in 2024, according to a new report by Aon. It found the top medical conditions driving health benefits plan costs are diabetes, autoimmune diseases (excluding diabetes), mental health, lung disorders/respiratory and cardiovascular and […]

  • By: Staff
  • November 20, 2024 November 19, 2024
  • 09:00

In light of the federal government developing a national pharmacare program, it’s important it considers the implementation of a national drug pooling program for private payers, says one expert. “If the government is going to invest in a universal drug program, it needs to have two main objectives,” said Edward Sabat, partner at The Consulting […]

  • By: Blake Wolfe
  • November 19, 2024 November 18, 2024
  • 09:00
Copyright_sdecoret_123RF

Most employees have experienced the powerful impact, whether positive or negative, that a manager can have on their work experience and overall well-being. As conversations about mental health become more common in the workplace, the expectation for support and accommodation has grown. However, many managers still feel unequipped and lack confidence in addressing mental-health issues […]

The weather is shifting, with the wet November wind blowing away the crisp October sunshine. While this time of year is characterized by the change of temperature and spectacular outdoor colours, the one constant at Benefits Canada and the Canadian Investment Review is that it’s our busiest time of year for events. In October, we […]

Cancer treatments represented 33 per cent of medicines in all phases of clinical trials in 2023, followed by treatments for infectious diseases (13 per cent) and central nervous system diseases (12 per cent), according to a new report by the Patented Medicine Prices Review Board. It found more than 12,000 new medicines were undergoing clinical […]

  • By: Staff
  • November 15, 2024 November 14, 2024
  • 09:00

With lyrics adapted to the tune of ‘Magic’ by Scottish pop group Pilot, the melody of ‘Oh, Oh, Oh, Ozempic’ is splashed across U.S. televisions in a snappy advertising campaign. The commercial push is likely unnecessary. Ozempic, one of the brand names of a glucagon-like peptide-1 receptor agonist medication used to treat type 2 diabetes, […]